Biomaterials as carrier, barrier and reactor for cell-based regenerative medicine

Abstract

Cell therapy has achieved tremendous success in regenerative medicine in the past several decades. However, challenges such as cell loss, death and immune-rejection after transplantation still persist. Biomaterials have been designed as carriers to deliver cells to desirable region for local tissue regeneration; as barriers to protect transplanted cells from host immune attack; or as reactors to stimulate host cell recruitment, homing and differentiation. With the assistance of biomaterials, improvement in treatment efficiency has been demonstrated in numerous animal models of degenerative diseases compared with routine free cell-based therapy. Emerging clinical applications of biomaterial assisted cell therapies further highlight their great promise in regenerative therapy and even cure for complex diseases, which have been failed to realize by conventional therapeutic approaches.

Key words： carrier; barrier; reactor; biomaterialassisted therapy; regenerative medicine

References

1 Agata H (2010) Characteristic change and loss of in vivo osteogenic abilities of human bone marrow stromal cells during passage. Tissue Eng Part A 16(2): 663―673

2 Antosiak-Iwanska M (2009) Isolation, banking, encapsulation and transplantation of different types of Langerhans islets. Pol Arch Med Wewn 119(5): 311―317

3 Astradsson A, Aziz TZ (2015) Parkinson’s disease: fetal cell or stem cell-derived treatments. BMJ Clin Evid 2015: 431―439

4 Avci-Adali M (2008) New strategies for in vivo tissue engineering by mimicry of homing factors for self-endothelialisation of blood contacting materials. Biomaterials 29(29): 3936―3945

5 Ayvazyan A (2011) Collagen-gelatin scaffold impregnated with bFGF accelerates palatal wound healing of palatal mucosa in dogs. J Surg Res 171(2): e247―e257

6 Bader A (1998) Tissue engineering of heart valves-human endothelial cell seeding of detergent acellularized porcine valves. Eur J Cardiothorac Surg 14(3): 279―284

7 Badylak SF (1995) The use of xenogeneic small intestinal submucosa as a biomaterial for Achilles tendon repair in a dog model. J Biomed Mater Res 29(8): 977―985

8 Badylak SF, Taylor D, Uygun K (2011) Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng 13: 27―53

9 Balasundaram G, Webster TJ (2007) An overview of nano-polymers for orthopedic applications. Macromol Biosci 7(5): 635―642

10 Barczyk M, Schmidt M, Mattoli S (2015) Stem cell-based therapy in idiopathic pulmonary fibrosis. Stem Cell Rev 21: 1550―8943

11 Bashkin P (1989) Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 28(4): 1737―1743

12 Bello YM, Falabella AF, Eaglstein WH (2001) Tissue-engineered skin. Current status in wound healing. Am J Clin Dermatol 2(5): 305―313

13 Blumenthal B (2010) Polyurethane scaffolds seeded with genetically engineered skeletal myoblasts: a promising tool to regenerate myocardial function. Artif Organs 34(2): E46―E54

14 Booth C (2002) Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold. J Heart Valve Dis 11(4): 457―462

15 Borschel GH, Dennis RG, Kuzon WM Jr (2004) Contractile skeletal muscle tissue-engineered on an acellular scaffold. Plast Reconstr Surg 113(2): 595―602

16 Borselli C (2011) The role of multifunctional delivery scaffold in the ability of cultured myoblasts to promote muscle regeneration. Biomaterials 32(34): 8905―8914

17 Brown KV (2011) Improving bone formation in a rat femur segmental defect by controlling bone morphogenetic protein-2 release. Tissue Eng Part A 17(13-14): 1735―1746

18 Butler CE (1999) Comparison of cultured and uncultured keratinocytes seeded into a collagen-GAG matrix for skin replacements. Br J Plast Surg 52(2): 127―132

19 Calafiore R (1999) Transplantation of pancreatic islets contained in minimal volume microcapsules in diabetic high mammalians. Ann N Y Acad Sci 875: 219―232

20 Cao Y (1997) Transplantation of chondrocytes utilizing a polymer-cell construct to produce tissue-engineered cartilage in the shape of a human ear. Plast Reconstr Surg 100(2): 297―302

21 Carpentier B, Gautier A, Legallais C (2009) Artificial and bioartificial liver devices: present and future. Gut 58(12): 1690―1702

22 Cartmell JS, Dunn MG (2000) Effect of chemical treatments on tendon cellularity and mechanical properties. J Biomed Mater Res 49(1): 134―140

23 Chamberlain LJ (2000) Near-terminus axonal structure and function following rat sciatic nerve regeneration through a collagen-GAG matrix in a ten-millimeter gap. J Neurosci Res 60(5): 666―677

24 Chan G, Mooney DJ (2008) New materials for tissue engineering: towards greater control over the biological response. Trends Biotechnol 26(7): 382―392

25 Chastain SR (2006) Adhesion of mesenchymal stem cells to polymer scaffolds occurs via distinct ECM ligands and controls their osteogenic differentiation. J Biomed Mater Res A 78(1): 73―85

26 Chen RN (2004) Process development of an acellular dermal matrix (ADM) for biomedical applications. Biomaterials 25(13): 2679―2686

27 Cheng TY (2013) Neural stem cells encapsulated in a functionalized self-assembling peptide hydrogel for brain tissue engineering. Biomaterials 34(8): 2005―2016

28 Cirone P (2002) A novel approach to tumor suppression with microencapsulated recombinant cells. Hum Gene Ther 13(10): 1157―1166

29 Colton CK (1995) Implantable biohybrid artificial organs. Cell Transplant 4(4): 415―436

30 Conklin BS (2002) Development and evaluation of a novel decellularized vascular xenograft. Med Eng Phys 24(3): 173―183

31 Cooper ML (1991) In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. Biomaterials 12(2): 243―248

32 Cortiella J (2010) Influence of acellular natural lung matrix on murine embryonic stem cell differentiation and tissue formation. Tissue Eng Part A 16(8): 2565―2580

33 Currie LJ, Sharpe JR, Martin R (2001) The use of fibrin glue in skin grafts and tissue-engineered skin replacements: a review. Plast Reconstr Surg 108(6): 1713―1726

34 Dahl SL (2003) Decellularized native and engineered arterial scaffolds for transplantation. Cell Transplant 12(6): 659―666

35 Daly AB (2012) Initial binding and recellularization of decellularized mouse lung scaffolds with bone marrow-derived mesenchymal stromal cells. Tissue Eng Part A 18(1-2): 1―16

36 David B (2004a) In vitro assessment of encapsulated C3A hepatocytes functions in a fluidized bed bioreactor. Biotechnol Prog 20(4): 1204―1212

37 David B (2004b) Mass transfers in a fluidized bed bioreactor using alginate beads for a future bioartificial liver. Int J Artif Organs 27(4): 284―293

38 de Graaff W (2003) Randomly inserted and targeted Hox/ reporter fusions transcriptionally silenced in Polycomb mutants. Proc Natl Acad Sci USA 100(23): 13362―13367

39 de Vos P, Marchetti P (2002) Encapsulation of pancreatic islets for transplantation in diabetes: the untouchable islets. Trends Mol Med 8(8): 363―366

40 De Vos P (1993) Obstacles in the application of microencapsulation in islet transplantation. Int J Artif Organs 16(4): 205―212

41 De Vos P (1997) Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets. Diabetologia 40(3): 262―270

42 Desai TA (1999) Microfabricated biocapsules provide shortterm immunoisolation of insulinoma xenografts. Biomed Microdevices 1(2): 131―138

43 Desai TA, Hansford DJ, Ferrari M (2000) Micromachined interfaces: new approaches in cell immunoisolation and biomolecular separation. Biomol Eng 17(1): 23―36

44 Dionne KE (1996) Transport characterization of membranes for immunoisolation. Biomaterials 17(3): 257―266

45 Dufrane D, Gianello P (2012) Macro- or microencapsulation of pig islets to cure type 1 diabetes. World J Gastroenterol 18(47): 6885―6893

46 Efrat S (2008) Beta-cell replacement for insulin-dependent diabetes mellitus. Adv Drug Deliv Rev 60(2): 114―123

47 Egana JT (2009) Use of human mesenchymal cells to improve vascularization in a mouse model for scaffold-based dermal regeneration. Tissue Eng Part A 15(5): 1191―1200

48 Elisseeff J (2000) Photoencapsulation of chondrocytes in poly (ethylene oxide)-based semi-interpenetrating networks. J Biomed Mater Res 51(2): 164―171

49 Elisseeff J (2006) The role of biomaterials in stem cell differentiation: applications in the musculoskeletal system. Stem Cells Dev 15(3): 295―303

50 Fisher RA, Strom SC (2006) Human hepatocyte transplantation: worldwide results. Transplantation 82(4): 441―449

51 Fishman JM (2013) Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model. Proc Natl Acad Sci USA 110(35): 14360―14365

52 Freytes DO (2004) Biaxial strength of multilaminated extracellular matrix scaffolds. Biomaterials 25(12): 2353―2361

53 Giancotti FG, Ruoslahti E (1999) Integrin signaling. Science 285(5430): 1028―1032

54 Gilbert TW (2005) Production and characterization of ECM powder: implications for tissue engineering applications. Biomaterials 26(12): 1431―1435

55 Gille J (2010) Mid-term results of Autologous Matrix-Induced Chondrogenesis for treatment of focal cartilage defects in the knee. Knee Surg Sports Traumatol Arthrosc 18(11): 1456―1464

56 Grandoso L (2007) Long-term survival of encapsulated GDNF secreting cells implanted within the striatum of parkinsonized rats. Int J Pharm 343(1-2): 69―78

57 Greenhalgh DG (2013) Treating a collagen scaffold with a low concentration of nicotine-promoted angiogenesis and wound healing. J Surg Res 185(2): 543―544

58 Hao S (2005) A novel approach to tumor suppression using microencapsulated engineered J558/TNF-alpha cells. Exp Oncol 27(1): 56―60

59 He M, Callanan A (2013) Comparison of methods for whole-organ decellularization in tissue engineering of bioartificial organs. Tissue Eng Part B Rev 19(3): 194―208

60 Hedberg EL (2005) Effect of varied release kinetics of the osteogenic thrombin peptide TP508 from biodegradable, polymeric scaffolds on bone formation in vivo. J Biomed Mater Res A 72(4): 343―353

61 Hernandez RM (2010) Microcapsules and microcarriers for in situ cell delivery. Adv Drug Deliv Rev 62(7-8): 711―730

62 Hinz B, Gabbiani G, Chaponnier C (2002) The NH2-terminal peptide of alpha-smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo. J Cell Biol 157(4): 657―663

63 Hofmann M (2005) Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111(17): 2198―2202

64 Hortelano G, Chang PL (2000) Gene therapy for hemophilia. Artif Cells Blood Substit Immobil Biotechnol 28(1): 1―24

65 Huang Q (2002) In vivo mesenchymal cell recruitment by a scaffold loaded with transforming growth factor beta1 and the potential for in situ chondrogenesis. Tissue Eng 8(3): 469―482

66 Hubbell JA (2003) Materials as morphogenetic guides in tissue engineering. Curr Opin Biotechnol 14(5): 551―558

67 Hudson TW, Liu SY, Schmidt CE (2004) Engineering an improved acellular nerve graft via optimized chemical processing. Tissue Eng 10(9-10): 1346―1358

68 Hunt NC, Grover LM (2010) Cell encapsulation using biopolymer gels for regenerative medicine. Biotechnol Lett 32(6): 733―742

69 Hwang NS (2008) In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc Natl Acad Sci USA 105(52): 20641―20646

70 Iwata H (1995) Does immunoisolation need to prevent the passage of antibodies and complements? Transplant Proc 27(6): 3224―3226

71 Jabbarzadeh E (2008) Induction of angiogenesis in tissueengineered scaffolds designed for bone repair: a combined gene therapy-cell transplantation approach. Proc Natl Acad Sci USA 105(32): 11099―11104

72 Ji R (2012) The differentiation of MSCs into functional hepatocyte-like cells in a liver biomatrix scaffold and their transplantation into liver-fibrotic mice. Biomaterials 33(35): 8995―9008

73 Kagami H, Agata H, Tojo A (2011) Bone marrow stromal cells (bone marrow-derived multipotent mesenchymal stromal cells) for bone tissue engineering: basic science to clinical translation. Int J Biochem Cell Biol 43(3): 286―289

74 Kang A (2014) Cell encapsulation via microtechnologies. Biomaterials 35(9): 2651―2663

75 Kasimir MT (2003) Comparison of different decellularization procedures of porcine heart valves. Int J Artif Organ 26(5): 421―427

76 Kearney CJ, Mooney DJ (2013) Macroscale delivery systems for molecular and cellular payloads. Nat Mater 12(11): 1004―1017

77 Khalil M (2001) Human hepatocyte cell lines proliferating as cohesive spheroid colonies in alginate markedly upregulate both synthetic and detoxificatory liver function. J Hepatol 34(1): 68―77

78 Kim BS, Baez CE, Atala A (2000) Biomaterials for tissue engineering. World J Urol 18(1): 2―9

79 Kim D (2001) Transplantation of genetically modified fibroblasts expressing BDNF in adult rats with a subtotal hemisection improves specific motor and sensory functions. Neurorehabil Neural Repair 15(2): 141―150

80 Kizilel S, Garfinkel M, Opara E (2005) The bioartificial pancreas: progress and challenges. Diabetes Technol Ther 7(6): 968―985

81 Klees RF (2008) Dissection of the osteogenic effects of laminin-332 utilizing specific LG domains: LG3 induces osteogenic differentiation, but not mineralization. Exp Cell Res 314(4): 763―773

82 Koffler J (2011) Improved vascular organization enhances functional integration of engineered skeletal muscle grafts. Proc Natl Acad Sci USA 108(36): 14789―14794

83 Kofron MD, Laurencin CT (2006) Bone tissue engineering by gene delivery. Adv Drug Deliv Rev 58(4): 555―576

84 Kolambkar YM (2011) An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects. Biomaterials 32(1): 65―74

85 Koshy ST (2014) Injectable, porous, and cell-responsive gelatin cryogels. Biomaterials 35(8): 2477―2487

86 Krishnamurthy NV, Gimi B (2011) Encapsulated cell grafts to treat cellular deficiencies and dysfunction. Crit Rev Biomed Eng 39(6): 473―491

87 Krol S (2006) Multilayer nanoencapsulation. New approach for immune protection of human pancreatic islets. Nano Lett 6(9): 1933―1939

88 Kulig KM, Vacanti JP (2004) Hepatic tissue engineering. Transpl Immunol 12(3-4): 303―310

89 Kumar A (1999) bcl2 and v-abl oncogenes cooperate to immortalize murine B cells that secrete antigen specific antibodies. Immunol Lett 65(3): 153―159

90 Kyriakides TR (1999) Mice that lack the angiogenesis inhibitor, thrombospondin 2, mount an altered foreign body reaction characterized by increased vascularity. Proc Natl Acad Sci USA 96(8): 4449―4454

91 Lacy PE (1991) Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science 254(5039): 1782―1784

92 Langer R, Vacanti JP (1993) Tissue engineering. Science 260(5110): 920―926

93 Lee CH (2010) Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study. Lancet 376(9739): 440―448

94 Li S (2010) Activin A binds to perlecan through its pro-region that has heparin/heparan sulfate binding activity. J Biol Chem 285(47): 36645―36655

95 Li Y (2014) Primed 3D injectable microniches enabling lowdosage cell therapy for critical limb ischemia. Proc Natl Acad Sci USA 111(37): 13511―13516

96 Liem PH (2013) Treating a collagen scaffold with a low concentration of nicotine promoted angiogenesis and wound healing. J Surg Res 182(2): 353―361

97 Lim F, Sun AM (1980) Microencapsulated islets as bioartificial endocrine pancreas. Science 210(4472): 908―910

98 Lin P (2004) Assessing porcine liver-derived biomatrix for hepatic tissue engineering. Tissue Eng 10(7-8): 1046―1053

99 Liu Tsang V (2007) Fabrication of 3D hepatic tissues by additive photopatterning of cellular hydrogels. FASEB J 21(3): 790―801

100 Liu W (2014) Microcryogels as injectable 3-D cellular microniches for site-directed and augmented cell delivery. Acta Biomater 10(5): 1864―1875

101 Lutolf MP, Hubbell JA (2005) Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 23(1): 47―55

102 Lutolf MP, Gilbert PM, Blau HM (2009) Designing materials to direct stem-cell fate. Nature 462(7272): 433―441

103 Lynch SE (1987) Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors. Proc Natl Acad Sci USA 84(21): 7696―7700

104 Malafaya PB, Silva GA, Reis RL (2007) Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv Drug Deliv Rev 59(4-5): 207―233

105 Marston WA (2003) The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 26(6): 1701―1705

106 Martino MM, Hubbell JA (2010) The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factorbinding domain. FASEB J 24(12): 4711―4721

107 Martino MM (2010) Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing. Sci Transl Med 3(100): 100ra89

108 Matthews JA (2002) Electrospinning of collagen nanofibers. Biomacromolecules 3(2): 232―238

109 McLaughlin CR (2009) Bioengineered corneas for transplantation and in vitro toxicology. Front Biosci (Landmark Ed) 14: 3326―3337

110 Meijer GJ (2008) Cell based bone tissue engineering in jaw defects. Biomaterials 29(21): 3053―3061

111 Metcalfe AD, Ferguson MW (2007) Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration. J R Soc Interface 4(14): 413―437

112 Mooney DJ, Vandenburgh H (2008) Cell delivery mechanisms for tissue repair. Cell Stem Cell 2(3): 205―213

113 Mooney DJ (1995) Biodegradable sponges for hepatocyte transplantation. J Biomed Mater Res 29(8): 959―965

114 Nafea EH (2011) Immunoisolating semi-permeable membranes for cell encapsulation: focus on hydrogels. J Control Release 154(2): 110―122

115 Nicodemus GD, Bryant SJ (2008) Cell encapsulation in biodegradable hydrogels for tissue engineering applications. Tissue Eng Part B 14(2): 149―165

116 Noth U, Steinert AF, Tuan RS (2008) Technology insight: adult mesenchymal stem cells for osteoarthritis therapy. Nat Clin Pract Rheumatol 4(7): 371―380

117 Okamoto T (2003) Cartilage regeneration using slow release of bone morphogenetic protein-2 from a gelatin sponge to treat experimental canine tracheomalacia: a preliminary report. ASAIO J 49(1): 63―69

118 Omer A (2005) Long-term normoglycemia in rats receiving transplants with encapsulated islets. Transplantation 79(1): 52―58

119 Orive G (2003) Cell encapsulation: promise and progress. Nat Med 9(1): 104―107

120 Orive G (2005) Long-term expression of erythropoietin from myoblasts immobilized in biocompatible and neovascularized microcapsules. Mol Ther 12(2): 283―289

121 O’Sullivan ES (2011) Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remain. Endocr Rev 32(6): 827―844

122 Ott HC (2008) Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart. Nat Med 14(2): 213―221

123 Paredes Juarez GA (2014) Immunological and technical considerations in application of alginate-based microencapsulation systems. Front Bioeng. Biotechnol 2: 26

124 Park H (2007) Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. Biomaterials 28(21): 3217―3227

125 Paul A (2009) Microencapsulated stem cells for tissue repairing: implications in cell-based myocardial therapy. Regen Med 4(5): 733―745

126 Peng H (2002) Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110(6): 751―759

127 Pepper AR (2015) A prevascularized subcutaneous device-less site for islet and cellular transplantation. Nat Biotechnol 33: 518―523

128 Petersen TH (2010) Tissue-engineered lungs for in vivo implantation. Science 329(5991): 538―541

129 Peterson B (2005) Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng 11(1-2): 120―129

130 Pouch SM (2015) Infectious complications of pancreatic islet transplantation: clinical experience and unanswered questions. Curr Infect Dis Rep 17(5): 482

131 Prakash S, Chang TM(1996) Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats. Nat Med 2(8): 883―887

132 Price AP (2010) Development of a decellularized lung bioreactor system for bioengineering the lung: the matrix reloaded. Tissue Eng Part A 16(8): 2581―2591

133 Rosario DJ (2008) Decellularization and sterilization of porcine urinary bladder matrix for tissue engineering in the lower urinary tract. Regen Med 3(2): 145―156

134 Sahni A, Odrljin T, Francis CW(1998) Binding of basic fibroblast growth factor to fibrinogen and fibrin. J Biol Chem 273(13): 7554―7559

135 Scharp DW, Marchetti P (2014) Encapsulated islets for diabetes therapy: history, current progress, and critical issues requiring solution. Adv Drug Deliv Rev 67-68: 35―73

136 Schechner JS (2003) Engraftment of a vascularized human skin equivalent. FASEB J 17(15): 2250―2256

137 Schneider S (2001) Multilayer capsules: a promising microencapsulation system for transplantation of pancreatic islets. Biomaterials 22(14): 1961―1970

138 Sellitto P (1995) Pressure-induced Hall-effect spectroscopy of silicon DX states in planar doped GaAs-AlAs superlattices. Phys Rev B 51(23): 16778―16784

139 Silva EA (2008) Material-based deployment enhances efficacy of endothelial progenitor cells. Proc Natl Acad Sci USA 105(38): 14347―14352

140 Simmons CA (2004) Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 35(2): 562―569

141 Street CN, Rajotte RV, Korbutt GS (2003) Stem cells: a promising source of pancreatic islets for transplantation in type 1 diabetes. Curr Top Dev Biol 58: 111―136

142 Stupack DG, Cheresh DA (2002) Get a ligand, get a life: integrins, signaling and cell survival. J Cell Sci 115(Pt 19): 3729―3738

143 Sugiyama O (2005) Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo. Mol Ther 11(3): 390―398

144 Ti D (2014) Controlled release of thymosin beta 4 using a collagen-chitosan sponge scaffold augments cutaneous wound healing and increases angiogenesis in diabetic rats with hindlimb ischemia. Tissue Eng Part A 20(21-22): 3085―3087

145 Tomatsu S (2015) Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome. Drug Des Devel Ther 9: 1937―1953

146 Uchimura E (2003) Novel method of preparing acellular cardiovascular grafts by decellularization with poly(ethylene glycol). J Biomed Mater Res A 67(3): 834―837

147 Uludag H, De Vos P, Tresco PA (2000a) Technology of mammalian cell encapsulation. Adv Drug Deliv Rev 42(1-2): 29―64

148 Uludag H (2000b) Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers: A correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model. J Biomed Mater Res 50(2): 227―238

149 Valentin JE (2006) Extracellular matrix bioscaffolds for orthopaedic applications. A comparative histologic study. J Bone Joint Surg Am 88(12): 2673―2686

150 van der Windt DJ (2007) Rapid loss of intraportally transplanted islets: an overview of pathophysiology and preventive strategies. Xenotransplantation 14(4): 288―297

151 Vermonden T (2008) Photopolymerized thermosensitive hydrogels: synthesis, degradation, and cytocompatibility. Biomacromolecules 9(3): 919―926

152 Wainwright JM (2010) Preparation of cardiac extracellular matrix from an intact porcine heart. Tissue Eng Part C 16(3): 525―532

153 Wang T (1997) An encapsulation system for the immunoisolation of pancreatic islets. Nat Biotechnol 15(4): 358―362

154 Wang C, Varshney RR, Wang DA (2010) Therapeutic cell delivery and fate control in hydrogels and hydrogel hybrids. Adv Drug Deliv Rev 62(7-8): 699―710

155 Webber MJ (2015) A perspective on the clinical translation of scaffolds for tissue engineering. Ann Biomed Eng 43(3): 641―656

156 Weber LM (2007) The effects of cell-matrix interactions on encapsulated beta-cell function within hydrogels functionalized with matrix-derived adhesive peptides. Biomaterials 28(19): 3004―3011

157 Weber LM, Cheung CY, Anseth KS (2008) Multifunctional pancreatic islet encapsulation barriers achieved via multilayer PEG hydrogels. Cell Transplant 16(10): 1049―1057

158 Wolf K (2003) Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 160(2): 267―277

159 Wong H, Chang TM (1991) A novel two step procedure for immobilizing living cells in microcapsules for improving xenograft survival. Biomater Artif Cells Immobil Biotechnol 19(4): 687―697

160 Woods T, Gratzer PF (2005) Effectiveness of three extraction techniques in the development of a decellularized bone-anterior cruciate ligament-bone graft. Biomaterials 26(35): 7339―7349

161 Wyman JL (2007) Immunoisolating pancreatic islets by encapsulation with selective withdrawal. Small 3(4): 683―690

162 Yamada Y (2004) Translational research for injectable tissueengineered bone regeneration using mesenchymal stem cells and platelet-rich plasma: from basic research to clinical case study. Cell Transplant 13(4): 343―355

163 Yang HK, Yoon KH (2015) Current status of encapsulated islet transplantation. J Diabetes Complications 4(1): e13―e17

164 Yoo JJ (1998) Bladder augmentation using allogenic bladder submucosa seeded with cells. Urology 51(2): 221―225

165 Zhang X (2008) A biodegradable, immunoprotective, dual nanoporous capsule for cell-based therapies. Biomaterials 29(31): 4253―4259

166 Zimmermann H, Shirley SG, Zimmermann U (2007) Alginate-based encapsulation of cells: past, present, and future. Curr Diab Rep 7(4): 314―320